We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

3 Trends I’m Watching

From drug development and clinical trials to manufacturing and supply chains, meet the Teva experts with their fingers on the pulse. Click on the headlines to read more and join the discussion.

Alyssa Fenoglio, VP Global Head of Digital Commercial

3 Trends I’m Watching in Pharmaceutical Marketing & Digital

Alyssa Fenoglio, VP Global Head of Digital Commercial, reveals 3 key trends in her sector – from AI and immersive technology to purpose-driven brand building and sustainability

colleagues sitting on a bench and discussing work

3 Trends I’m Watching in Sustainability

Amalia Adler-Waxman, SVP Head of Sustainability at Teva, discusses the key trends she’s keenly watching in the fast-paced area of sustainability, including integration, mandatory reporting and real-world measurable impacts

Eran Harary, Teva’s Head of Global Early Clinical Development

What are the 3 biggest elements shaping clinical development today?

Richard Daniell, Executive Vice President, European Commercial

Richard Daniell outlines key trends in global generics

Ravit Eshed - VP, Head of Talent Management at Teva

Ravit Eshed showcases new trends in the world of work

Dan Pritchett, VP External Manufacturing and Supply Operations (EMSO) Teva North America

Dan Pritchett explores new directions in supply chains and manufacturing

Amit Hazan Head of Corporate Finance and Banking Realtions

Amit Hazan reveals the fast-paced global finance trends he’s watching

Klaudija Marijanovic Barac MD shares trends in PV and patient safety

Dana Bar-On talks about big pharma healthcare trends

Dana Bar-On outlines exciting new moves in creative partnerships

Irit Hovich discusses important advances in workplace diversity

Erick Tyssier looks at resilient manufacturing and sustainability

Data scientist Michal Melamed talks about health care trends

Michal Melamed presents new tech innovations in pharma